Cognition Assessment in Virtual Reality: Validity and feasibility of a novel virtual reality test for real-life cognitive functions in mood disorders and psychosis spectrum disorders

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Cognition Assessment in Virtual Reality : Validity and feasibility of a novel virtual reality test for real-life cognitive functions in mood disorders and psychosis spectrum disorders. / Miskowiak, Kamilla W.; Jespersen, Andreas E.; Kessing, Lars, V; Aggestrup, Anne Sofie; Glenthoj, Louise B.; Nordentoft, Merete; Ott, Caroline, V; Lumbye, Anders.

I: Journal of Psychiatric Research, Bind 145, 01.2022, s. 182-189.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Miskowiak, KW, Jespersen, AE, Kessing, LV, Aggestrup, AS, Glenthoj, LB, Nordentoft, M, Ott, CV & Lumbye, A 2022, 'Cognition Assessment in Virtual Reality: Validity and feasibility of a novel virtual reality test for real-life cognitive functions in mood disorders and psychosis spectrum disorders', Journal of Psychiatric Research, bind 145, s. 182-189. https://doi.org/10.1016/j.jpsychires.2021.12.002

APA

Miskowiak, K. W., Jespersen, A. E., Kessing, L. V., Aggestrup, A. S., Glenthoj, L. B., Nordentoft, M., Ott, C. V., & Lumbye, A. (2022). Cognition Assessment in Virtual Reality: Validity and feasibility of a novel virtual reality test for real-life cognitive functions in mood disorders and psychosis spectrum disorders. Journal of Psychiatric Research, 145, 182-189. https://doi.org/10.1016/j.jpsychires.2021.12.002

Vancouver

Miskowiak KW, Jespersen AE, Kessing LV, Aggestrup AS, Glenthoj LB, Nordentoft M o.a. Cognition Assessment in Virtual Reality: Validity and feasibility of a novel virtual reality test for real-life cognitive functions in mood disorders and psychosis spectrum disorders. Journal of Psychiatric Research. 2022 jan.;145:182-189. https://doi.org/10.1016/j.jpsychires.2021.12.002

Author

Miskowiak, Kamilla W. ; Jespersen, Andreas E. ; Kessing, Lars, V ; Aggestrup, Anne Sofie ; Glenthoj, Louise B. ; Nordentoft, Merete ; Ott, Caroline, V ; Lumbye, Anders. / Cognition Assessment in Virtual Reality : Validity and feasibility of a novel virtual reality test for real-life cognitive functions in mood disorders and psychosis spectrum disorders. I: Journal of Psychiatric Research. 2022 ; Bind 145. s. 182-189.

Bibtex

@article{d83e7b50ef764c518f5644081b919d24,
title = "Cognition Assessment in Virtual Reality: Validity and feasibility of a novel virtual reality test for real-life cognitive functions in mood disorders and psychosis spectrum disorders",
abstract = "There is a pressing need for measures of real-life cognitive functioning in patients with mood or psychotic disorders in clinical settings and treatment trials targeting cognition. We developed the first immersive virtual reality cognition assessment tool, the Cognition Assessment in Virtual Reality (CAVIR), which assesses verbal memory, processing speed, attention, working memory and planning skills in an interactive virtual reality kitchen scenario. This study investigates the sensitivity and validity of the CAVIR for cognitive impairments in mood and psychotic disorders and its association with functioning and neuropsychological performance. Symptomatically stable patients with mood disorders (MD; n = 40) or psychosis spectrum disorders (PSD; n = 41) and healthy control participants (HC; n = 40) completed the CAVIR and standard neuropsychological tests and were rated for clinical symptoms and daily functioning. We found that the CAVIR was sensitive to cognitive impairments across MD and PSD with large effect sizes (MD: F(73) = 11.61, p < .01, ηp2 = 0.14; PSD: F(72) = 18.24, p < .001, ηp2 = 0.19). There was a moderate to strong positive correlation between performance on the CAVIR and on neuropsychological tests (r(121) = 0.58, p < .001), which prevailed after adjustment for age, years of education and verbal IQ (B = 0.67, p < .001). Lower CAVIR scores correlated moderately with more observer-rated and performance-based functional disability (r(121) = -0.30, p < .01 and r(68) = 0.44, p < .001, respectively), also after adjustment for age, years of education and verbal IQ (B = 0.03, p < .001). In conclusion, the CAVIR is a sensitive and valid instrument for measuring real-life cognitive impairments in mood and psychotic disorders. After further psychometric assessments, the CAVIR can be implemented in clinical settings and trials targeting cognition.",
keywords = "Virtual reality, Cognition, Assessment, Bipolar disorder, Psychosis",
author = "Miskowiak, {Kamilla W.} and Jespersen, {Andreas E.} and Kessing, {Lars, V} and Aggestrup, {Anne Sofie} and Glenthoj, {Louise B.} and Merete Nordentoft and Ott, {Caroline, V} and Anders Lumbye",
year = "2022",
month = jan,
doi = "10.1016/j.jpsychires.2021.12.002",
language = "English",
volume = "145",
pages = "182--189",
journal = "Journal of Psychiatric Research",
issn = "0022-3956",
publisher = "Pergamon Press",

}

RIS

TY - JOUR

T1 - Cognition Assessment in Virtual Reality

T2 - Validity and feasibility of a novel virtual reality test for real-life cognitive functions in mood disorders and psychosis spectrum disorders

AU - Miskowiak, Kamilla W.

AU - Jespersen, Andreas E.

AU - Kessing, Lars, V

AU - Aggestrup, Anne Sofie

AU - Glenthoj, Louise B.

AU - Nordentoft, Merete

AU - Ott, Caroline, V

AU - Lumbye, Anders

PY - 2022/1

Y1 - 2022/1

N2 - There is a pressing need for measures of real-life cognitive functioning in patients with mood or psychotic disorders in clinical settings and treatment trials targeting cognition. We developed the first immersive virtual reality cognition assessment tool, the Cognition Assessment in Virtual Reality (CAVIR), which assesses verbal memory, processing speed, attention, working memory and planning skills in an interactive virtual reality kitchen scenario. This study investigates the sensitivity and validity of the CAVIR for cognitive impairments in mood and psychotic disorders and its association with functioning and neuropsychological performance. Symptomatically stable patients with mood disorders (MD; n = 40) or psychosis spectrum disorders (PSD; n = 41) and healthy control participants (HC; n = 40) completed the CAVIR and standard neuropsychological tests and were rated for clinical symptoms and daily functioning. We found that the CAVIR was sensitive to cognitive impairments across MD and PSD with large effect sizes (MD: F(73) = 11.61, p < .01, ηp2 = 0.14; PSD: F(72) = 18.24, p < .001, ηp2 = 0.19). There was a moderate to strong positive correlation between performance on the CAVIR and on neuropsychological tests (r(121) = 0.58, p < .001), which prevailed after adjustment for age, years of education and verbal IQ (B = 0.67, p < .001). Lower CAVIR scores correlated moderately with more observer-rated and performance-based functional disability (r(121) = -0.30, p < .01 and r(68) = 0.44, p < .001, respectively), also after adjustment for age, years of education and verbal IQ (B = 0.03, p < .001). In conclusion, the CAVIR is a sensitive and valid instrument for measuring real-life cognitive impairments in mood and psychotic disorders. After further psychometric assessments, the CAVIR can be implemented in clinical settings and trials targeting cognition.

AB - There is a pressing need for measures of real-life cognitive functioning in patients with mood or psychotic disorders in clinical settings and treatment trials targeting cognition. We developed the first immersive virtual reality cognition assessment tool, the Cognition Assessment in Virtual Reality (CAVIR), which assesses verbal memory, processing speed, attention, working memory and planning skills in an interactive virtual reality kitchen scenario. This study investigates the sensitivity and validity of the CAVIR for cognitive impairments in mood and psychotic disorders and its association with functioning and neuropsychological performance. Symptomatically stable patients with mood disorders (MD; n = 40) or psychosis spectrum disorders (PSD; n = 41) and healthy control participants (HC; n = 40) completed the CAVIR and standard neuropsychological tests and were rated for clinical symptoms and daily functioning. We found that the CAVIR was sensitive to cognitive impairments across MD and PSD with large effect sizes (MD: F(73) = 11.61, p < .01, ηp2 = 0.14; PSD: F(72) = 18.24, p < .001, ηp2 = 0.19). There was a moderate to strong positive correlation between performance on the CAVIR and on neuropsychological tests (r(121) = 0.58, p < .001), which prevailed after adjustment for age, years of education and verbal IQ (B = 0.67, p < .001). Lower CAVIR scores correlated moderately with more observer-rated and performance-based functional disability (r(121) = -0.30, p < .01 and r(68) = 0.44, p < .001, respectively), also after adjustment for age, years of education and verbal IQ (B = 0.03, p < .001). In conclusion, the CAVIR is a sensitive and valid instrument for measuring real-life cognitive impairments in mood and psychotic disorders. After further psychometric assessments, the CAVIR can be implemented in clinical settings and trials targeting cognition.

KW - Virtual reality

KW - Cognition

KW - Assessment

KW - Bipolar disorder

KW - Psychosis

U2 - 10.1016/j.jpsychires.2021.12.002

DO - 10.1016/j.jpsychires.2021.12.002

M3 - Journal article

C2 - 34923359

VL - 145

SP - 182

EP - 189

JO - Journal of Psychiatric Research

JF - Journal of Psychiatric Research

SN - 0022-3956

ER -

ID: 291542976